课题基金 / 基金详情

FATTY ACID AND KETONE BODY METABOLISM--ENZYME ISOLATION

FATTY ACID AND KETONE BODY METABOLISM--ENZYME ISOLATION
脂肪酸和酮体代谢--酶分离
批准号:
3151395
负责人:
DOMINICK L CINTI
金额:
$19.45万
依托单位国家:
美国
项目类别:
财政年份:
1978
资助国家:
美国
项目状态:
已结题
起止时间:
1978-09-01 至 1987-08-31

项目摘要

项目成果

DOMINICK L CINTI的其他基金

相似基金

相关文献

中文摘要
翻译
这一建议是我们对隔离问题研究的延续
英文摘要
This proposal is a continuation of our studies concerned with the isolation of components of the liver microsomal fatty acid chain elongation system. Our recent discovery of a microsomal short chain fatty acid reduction system which catalyzes reactions that are identical to those found in the long chain fatty acid elongation system, has made the separation of components no simple task, and has made us aware of the ever increasing complexity of the liver endoplasmic reticulum. Our primary focus will be the separation of these two systems, i.e., the separation of the two Beta-keto acyl CoA reductases (the short-chain Beta-keto reductase which we have called acetoacetyl CoA reductase versus the long chain Beta-keto reductase which utilizes Beta-ketopalmitoyl CoA or Beta-keto stearoyl CoA as substrates), separation of the two dehydratases and the two trans-2, 3-enoyl CoA reductases. Purification of the individual component enzymes will be our continued goal, followed by reconstitution of the short-chain and long-chain systems. A role for cytochrome b5, its flavoprotein reductase and NADPH cytochrome P-450 reductase in the short chain reductase system will be assessed; the role of phospholipid and other lipids will also be investigated. Another major goal of the proposal is the elucidation of regulation or modulation of both the microsomal fatty acid chain elongation system and the short chain acyl CoA reduction system. To this end, we will determine the role of dietary factors, diabetes, insulin, and glucagon in the control of these two systems. The diabetic animal may be especially important in determining the physiological importance of our newly discovered short-chain acyl CoA reduction system, since an important substrate of this enzyme system is acetoacetyl CoA, a ketone body precursor. Finally, do pharmacologic agents, like clofibrate cholestyramine which induce hypolipidemia exert a significant effect on these two microsomal systems? Our proposal should contribute significantly to our understanding of lipid metabolism.
期刊论文(29)
专著(0)
科研奖励(0)
会议论文
Source of the hepatic microsomal trans-2-enoyl CoA hydratase bifunctional protein: endoplasmic reticulum or peroxisomes.
肝微粒体反式2-烯酰辅酶A水合酶双功能蛋白的来源:内质网或过氧化物酶体。
DOI: 10.1016/0003-9861(87)90043-9
发表时间: 1987
期刊: Archives of biochemistry and biophysics
影响因子: 3.9
作者: [Ghesquier,D, Cook,L, Nagi,MN, MacAlister,TJ, Cinti,DL]
通讯作者: Cinti,DL
DOI: 10.1016/s0021-9258(19)68742-9
发表时间: 1981-10
期刊: The Journal of biological chemistry
影响因子: --
作者: [Z. Ilan;R. Ilan;D. L. Cinti]
通讯作者: Z. Ilan;R. Ilan;D. L. Cinti
Do rat hepatic microsomes contain multiple NADPH-supported fatty acid chain elongation pathways or a single pathway?
大鼠肝微粒体包含多个 NADPH 支持的脂肪酸链延长途径还是单一途径?
DOI: 10.1016/0006-291x(86)91059-4
发表时间: 1986
期刊: Biochemical and biophysical research communications
影响因子: 3.1
作者: [Nagi,MN, Cook,L, Prasad,MR, Cinti,DL]
通讯作者: Cinti,DL
Evidence for two separate beta-ketoacyl CoA reductase components of the hepatic microsomal fatty acid chain elongation system in the rat.
大鼠肝微粒体脂肪酸链延长系统中两个独立的 β-酮脂酰 CoA 还原酶成分的证据。
DOI: 10.1016/0006-291x(89)91547-7
发表时间: 1989
期刊: Biochemical and biophysical research communications
影响因子: 3.1
作者: [Nagi,MN, Cook,L, Suneja,SK, Peluso,PS, Laguna,JC, Osei,P, Cinti,DL]
通讯作者: Cinti,DL
26
    MEDICAL SCIENTIST TRAINING PROGRAM
    MEDICAL SCIENTIST TRAINING PROGRAM
    MEDICAL SCIENTIST TRAINING PROGRAM
    MEDICAL SCIENTIST TRAINING PROGRAM
    海外基金